https://investors.korumedical.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_6a8cb2e104d0f876ca801f66e12ac08c/korumedical/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://investors.korumedical.com/news-events/press-releases/detail/198/koru-medical-systems-to-report-first-quarter-2026-financial-results-on-may-6-2026 Thu, 16 Apr 26 08:00:00 -0400 https://investors.korumedical.com/news-events/press-releases/detail/198/koru-medical-systems-to-report-first-quarter-2026-financial-results-on-may-6-2026 https://investors.korumedical.com/news-events/press-releases/detail/197/koru-medical-systems-announces-eu-mdr-certification-for-the-freedom60-infusion-pump-with-prefilled-syringe-compatibility Fri, 13 Mar 26 08:00:00 -0400 https://investors.korumedical.com/news-events/press-releases/detail/197/koru-medical-systems-announces-eu-mdr-certification-for-the-freedom60-infusion-pump-with-prefilled-syringe-compatibility https://investors.korumedical.com/news-events/press-releases/detail/196/koru-medical-systems-announces-ceo-transition Thu, 12 Mar 26 16:08:00 -0400 https://investors.korumedical.com/news-events/press-releases/detail/196/koru-medical-systems-announces-ceo-transition https://investors.korumedical.com/news-events/press-releases/detail/195/koru-medical-systems-announces-20-fourth-quarter-and-full-year-2025-revenue-growth-positive-adjusted-ebitda-and-initiates-full-year-2026-guidance Thu, 12 Mar 26 16:05:00 -0400 https://investors.korumedical.com/news-events/press-releases/detail/195/koru-medical-systems-announces-20-fourth-quarter-and-full-year-2025-revenue-growth-positive-adjusted-ebitda-and-initiates-full-year-2026-guidance https://investors.korumedical.com/news-events/press-releases/detail/194/koru-medical-systems-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-12-2026 Thu, 26 Feb 26 16:05:00 -0500 https://investors.korumedical.com/news-events/press-releases/detail/194/koru-medical-systems-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-12-2026 https://investors.korumedical.com/news-events/press-releases/detail/193/koru-medical-systems-receives-fda-510k-clearance-for-delivery-of-rystiggo-rozanolixizumab-noli-expanding-label-for-freedomedge-infusion-system Thu, 29 Jan 26 16:05:00 -0500 https://investors.korumedical.com/news-events/press-releases/detail/193/koru-medical-systems-receives-fda-510k-clearance-for-delivery-of-rystiggo-rozanolixizumab-noli-expanding-label-for-freedomedge-infusion-system https://investors.korumedical.com/news-events/press-releases/detail/192/koru-medical-systems-reports-preliminary-q4-and-full-year-2025-results-achieves-record-revenue-and-full-year-positive-operating-cash-flow Mon, 12 Jan 26 08:00:00 -0500 https://investors.korumedical.com/news-events/press-releases/detail/192/koru-medical-systems-reports-preliminary-q4-and-full-year-2025-results-achieves-record-revenue-and-full-year-positive-operating-cash-flow https://investors.korumedical.com/news-events/press-releases/detail/191/koru-medical-systems-announces-inducement-grant-under-nasdaq-listing-rule-5635c4 Mon, 05 Jan 26 07:00:00 -0500 https://investors.korumedical.com/news-events/press-releases/detail/191/koru-medical-systems-announces-inducement-grant-under-nasdaq-listing-rule-5635c4 https://investors.korumedical.com/news-events/press-releases/detail/190/koru-medical-systems-announces-510k-submission-for-clearance-of-the-freedomedge-system-with-a-commercialized-oncology-biologic Tue, 30 Dec 25 16:05:00 -0500 https://investors.korumedical.com/news-events/press-releases/detail/190/koru-medical-systems-announces-510k-submission-for-clearance-of-the-freedomedge-system-with-a-commercialized-oncology-biologic https://investors.korumedical.com/news-events/press-releases/detail/189/koru-medical-systems-inc-appoints-eric-schiller-as-chief-technology-officer Tue, 16 Dec 25 16:05:00 -0500 https://investors.korumedical.com/news-events/press-releases/detail/189/koru-medical-systems-inc-appoints-eric-schiller-as-chief-technology-officer